BMY Bristol Myers Squibb Co

Price (delayed)

$71.71

Market cap

$153.12B

P/E Ratio

23.59

Dividend/share

$2.11

EPS

$3.04

Enterprise value

$184.43B

Bristol Myers Squibb is an American pharmaceutical company, headquartered in New York City. Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, ...

Highlights
Bristol Myers Squibb's gross profit has increased by 11% YoY
Bristol Myers Squibb's EPS has increased by 7% QoQ
Bristol Myers Squibb's equity has decreased by 11% YoY but it has increased by 3.2% from the previous quarter
The quick ratio has decreased by 8% YoY but it has increased by 3.9% QoQ

Key stats

What are the main financial stats of BMY
Market
Shares outstanding
2.14B
Market cap
$153.12B
Enterprise value
$184.43B
Valuations
Price to earnings (P/E)
23.59
Price to book (P/B)
4.68
Price to sales (P/S)
3.24
EV/EBIT
24.14
EV/EBITDA
10.18
EV/Sales
3.91
Earnings
Revenue
$47.14B
EBIT
$7.64B
EBITDA
$18.11B
Free cash flow
$14.28B
Per share
EPS
$3.04
Free cash flow per share
$6.71
Book value per share
$15.31
Revenue per share
$22.14
TBVPS
$19.83
Balance sheet
Total assets
$100.36B
Total liabilities
$67.7B
Debt
$42.06B
Equity
$32.6B
Working capital
$9.27B
Liquidity
Debt to equity
1.29
Current ratio
1.44
Quick ratio
1.07
Net debt/EBITDA
1.73
Margins
EBITDA margin
38.4%
Gross margin
79.1%
Net margin
14%
Operating margin
16.2%
Efficiency
Return on assets
6.2%
Return on equity
19.3%
Return on invested capital
14.2%
Return on capital employed
9.6%
Return on sales
16.2%
Dividend
Dividend yield
2.94%
DPS
$2.11
Payout ratio
69.4%

BMY stock price

How has the Bristol Myers Squibb stock price performed over time
Intraday
-0.49%
1 week
0.59%
1 month
7.43%
1 year
18.29%
YTD
15.01%
QTD
-6.87%

Financial performance

How have Bristol Myers Squibb's revenue and profit performed over time
Revenue
$47.14B
Gross profit
$37.31B
Operating income
$7.66B
Net income
$6.62B
Gross margin
79.1%
Net margin
14%
Bristol Myers Squibb's gross profit has increased by 11% YoY
The company's revenue rose by 6% YoY
The net income has grown by 6% since the previous quarter
The operating income rose by 6% since the previous quarter

Growth

What is Bristol Myers Squibb's growth rate over time

Valuation

What is Bristol Myers Squibb stock price valuation
P/E
23.59
P/B
4.68
P/S
3.24
EV/EBIT
24.14
EV/EBITDA
10.18
EV/Sales
3.91
Bristol Myers Squibb's EPS has increased by 7% QoQ
Bristol Myers Squibb's equity has decreased by 11% YoY but it has increased by 3.2% from the previous quarter
BMY's P/B is 6% above its last 4 quarters average of 4.4 but 4.5% below its 5-year quarterly average of 4.9
The price to sales (P/S) is 15% less than the 5-year quarterly average of 3.8
The company's revenue rose by 6% YoY

Efficiency

How efficient is Bristol Myers Squibb business performance
The ROE has grown by 9% from the previous quarter
BMY's return on invested capital is up by 8% since the previous quarter
Bristol Myers Squibb's ROA has increased by 7% from the previous quarter
Bristol Myers Squibb's return on sales has increased by 5% QoQ

Dividends

What is BMY's dividend history
DPS
$2.11
Dividend yield
2.94%
Payout ratio
69.4%
Recent dividends

Financial health

How did Bristol Myers Squibb financials performed over time
BMY's total assets is 48% greater than its total liabilities
Bristol Myers Squibb's current ratio has increased by 9% from the previous quarter but it has decreased by 6% YoY
BMY's total assets is down by 9% year-on-year and by 2.6% since the previous quarter
BMY's debt is 29% greater than its equity
Bristol Myers Squibb's equity has decreased by 11% YoY but it has increased by 3.2% from the previous quarter
The company's debt to equity fell by 9% QoQ but it rose by 4.9% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.